Applications of nanotechnology for immunology (Q38123937)

29 August 2017

title

Applications of nanotechnology for immunology (English)

1 reference

29 August 2017

0 references

0 references

3

1 reference

29 August 2017

Douglas M Smith

1

1 reference

29 August 2017

Jakub K Simon

series ordinal

2

1 reference

29 August 2017

publication date

1 August 2013

1 reference

Nature Reviews Immunology

29 August 2017

published in

1 reference

29 August 2017

volume

13

1 reference

29 August 2017

issue

8

1 reference

29 August 2017

page(s)

592-605

1 reference

Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid

29 August 2017

cites work

1 reference

The dimensions of DNA in solution

21 January 2018

1 reference

Immunodrugs: therapeutic VLP-based vaccines for chronic diseases

21 January 2018

1 reference

Developments in virus-like particle-based vaccines for infectious diseases and cancer

21 January 2018

1 reference

Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients

21 January 2018

1 reference

Nanoparticles target distinct dendritic cell populations according to their size

21 January 2018

1 reference

In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.

21 January 2018

1 reference

Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors

21 January 2018

1 reference

Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.

21 January 2018

1 reference

Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A.

21 January 2018

1 reference

Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine

21 January 2018

1 reference

Translating tumor antigens into cancer vaccines

21 January 2018

1 reference

Human papillomavirus vaccine: Widening the scope for cancer prevention

21 January 2018

1 reference

Promotion of B cell immune responses via an alum-induced myeloid cell population

21 January 2018

1 reference

(How) do aluminium adjuvants work?

21 January 2018

1 reference

The global impact of vaccination against hepatitis B: a historical overview

21 January 2018

1 reference

Synthetic virus-like particles from self-assembling coiled-coil lipopeptides and their use in antigen display to the immune system

21 January 2018

1 reference

The role of antibodies in HIV vaccines

21 January 2018

1 reference

Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles

21 January 2018

1 reference

Synthetic virus-like particles and conformationally constrained peptidomimetics in vaccine design

21 January 2018

1 reference

Engineered synthetic virus-like particles and their use in vaccine delivery

21 January 2018

1 reference

Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines

21 January 2018

1 reference

Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions

21 January 2018

1 reference

Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding

21 January 2018

1 reference

HIV-1 Vaccine Trials: Evolving Concepts and Designs

21 January 2018

1 reference

Application of nanotechnologies for improved immune response against infectious diseases in the developing world

21 January 2018

1 reference

Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives

21 January 2018

1 reference

Hydrogel-Delivered GM-CSF Overcomes Nonresponsiveness to Hepatitis B Vaccine through the Recruitment and Activation of Dendritic Cells

21 January 2018

1 reference

Repetitive versus monomeric antigen presentation: direct visualization of antibody affinity and specificity

21 January 2018

1 reference

Peptide nanoparticles serve as a powerful platform for the immunogenic display of poorly antigenic actin determinants

21 January 2018

1 reference

Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine

21 January 2018

1 reference

A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria

21 January 2018

1 reference

Emulsion-based adjuvants for influenza vaccines.

21 January 2018

1 reference

Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes

21 January 2018

1 reference

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

21 January 2018

1 reference

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

21 January 2018

1 reference

21 January 2018

Safety of MF59 adjuvant

1 reference

Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine

21 January 2018

1 reference

Nanoemulsion mucosal adjuvant uniquely activates cytokine production by nasal ciliated epithelium and induces dendritic cell trafficking.

21 January 2018

1 reference

Immunogenic and tolerogenic cell death

21 January 2018

1 reference

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species.

21 January 2018

1 reference

Antimicrobial mechanism of action of surfactant lipid preparations in enteric Gram-negative bacilli.

21 January 2018

1 reference

A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi

21 January 2018

1 reference

A novel, killed-virus nasal vaccinia virus vaccine

21 January 2018

1 reference

A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease

21 January 2018

1 reference

Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion.

21 January 2018

1 reference

Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine.

21 January 2018

1 reference

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge

21 January 2018

1 reference

Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates

21 January 2018

1 reference

Mucosal antibody response induced with a nasal virosome-based influenza vaccine.

21 January 2018

1 reference

A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells

21 January 2018

1 reference

Cationic liposomes as vaccine adjuvants

21 January 2018

1 reference

Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation

21 January 2018

1 reference

Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination

21 January 2018

1 reference

Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice

21 January 2018

1 reference

Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses

21 January 2018

1 reference

Nanoparticles and the immune system

21 January 2018

1 reference

In vivo biology and toxicology of fullerenes and their derivatives.

21 January 2018

1 reference

Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes

21 January 2018

1 reference

Fullerene derivatives: an attractive tool for biological applications

21 January 2018

1 reference

Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure

21 January 2018

1 reference

Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice

21 January 2018

1 reference

Research on the bioactivities of C60-dexamethasone.

21 January 2018

1 reference

Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo

21 January 2018

1 reference

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

21 January 2018

1 reference

Nanomedicines in renal transplant rejection--focus on sirolimus

21 January 2018

1 reference

Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation.

21 January 2018

1 reference

Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model

21 January 2018

1 reference

Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation.

21 January 2018

1 reference

Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses

21 January 2018

1 reference

Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers

21 January 2018

1 reference

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer

21 January 2018

1 reference

Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate

21 January 2018

1 reference

Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Modulation of CD4+ T Lymphocyte Lineage Outcomes with Targeted, Nanoparticle-Mediated Cytokine Delivery

21 January 2018

1 reference

Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.

21 January 2018

1 reference

PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity

21 January 2018

1 reference

Altering the immune response with lipid-based nanoparticles.

21 January 2018

1 reference

Recent developments in lipid-based pharmaceutical nanocarriers

21 January 2018

1 reference

Prevention of acute lung injury in swine: depletion of pulmonary intravascular macrophages using liposomal clodronate

21 January 2018

1 reference

Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate

21 January 2018

1 reference

Preparation of alendronate liposomes for enhanced stability and bioactivity: in vitro and in vivo characterization

21 January 2018

1 reference

Actively Targeted Low-Dose Camptothecin as a Safe, Long-Acting, Disease-Modifying Nanomedicine for Rheumatoid Arthritis

21 January 2018

1 reference

Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant.

21 January 2018

1 reference

Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide

21 January 2018

1 reference

Current insights in sepsis: from pathogenesis to new treatment targets

21 January 2018

1 reference

Endotoxin tolerance: new mechanisms, molecules and clinical significance

21 January 2018

1 reference

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

21 January 2018

1 reference

Adjuvants for cancer vaccines

21 January 2018

1 reference

Dynamic regulatory network controlling TH17 cell differentiation

21 January 2018

1 reference

Characterization of polysaccharide-protein complexes by size-exclusion chromatography combined with three detectors

21 January 2018

1 reference

Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy.

21 January 2018

1 reference

Crystal structure of human toll-like receptor 3 (TLR3) ectodomain

21 January 2018

1 reference

Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10.

21 January 2018

1 reference

Structural characterization of the TCR complex by electron microscopy

21 January 2018

1 reference

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

21 January 2018

1 reference

Structure and function of the B cell antigen receptor

21 January 2018

1 reference

Structure and function of the T cell antigen receptor

21 January 2018

1 reference

Eosinophils: structure and functions

21 January 2018

1 reference

Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity

21 January 2018

1 reference

Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery

21 January 2018

1 reference

Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.

21 January 2018

1 reference

Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia

21 January 2018

1 reference

NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors

21 January 2018

1 reference

The presumptive phosphatidylserine receptor is dispensable for innate anti-inflammatory recognition and clearance of apoptotic cells

21 January 2018

1 reference

Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro

21 January 2018

1 reference

Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response

21 January 2018

1 reference

Comparison of the Depot Effect and Immunogenicity of Liposomes Based on Dimethyldioctadecylammonium (DDA), 3β-[N-(N′,N′-Dimethylaminoethane)carbomyl] Cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium Propane (DOTAP): Prolonged Liposome

21 January 2018

1 reference

Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen

21 January 2018

1 reference

Exploiting lymphatic transport and complement activation in nanoparticle vaccines

21 January 2018

1 reference

Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen

31 March 2020

1 reference

The preparation and safety of hepatitis B vaccine

31 March 2020

1 reference

Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses

31 March 2020

1 reference

The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens

31 March 2020

2 references

31 March 2020

12 December 2020

Mechanisms of adjuvancy: I?metal oxides as adjuvants

1 reference

Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production

31 March 2020

1 reference

Novel nanoparticles for the delivery of recombinant hepatitis B vaccine

31 March 2020

1 reference

Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles

31 March 2020

1 reference

A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection

31 March 2020

1 reference

Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine

31 March 2020

1 reference

The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells

31 March 2020

1 reference

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

31 March 2020

1 reference

Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

31 March 2020

1 reference

Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens

31 March 2020

1 reference

Prevention of murine influenza A virus pneumonitis by surfactant nano-emulsions

31 March 2020

1 reference

Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine

31 March 2020

1 reference

Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes

31 March 2020

1 reference

Fullerene nanomaterials inhibit the allergic response

31 March 2020

1 reference

Induction of mucosal immune responses by administration of liposome-antigen formulations and interleukin-12

31 March 2020

1 reference

A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation

31 March 2020

1 reference

Nanomedicines for inflammatory diseases

31 March 2020

1 reference

Induction of immune tolerance in mice with a novel mucosal nanoemulsion adjuvant and self-antigen

31 March 2020

1 reference

Dendritic cells: immune regulators in health and disease

31 March 2020

1 reference

HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan

31 March 2020

1 reference

Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy

31 March 2020

1 reference

The heritage of hepatitis B vaccine

31 March 2020

1 reference

12 December 2020

Cell size of alveolar macrophages: an interspecies comparison

1 reference

12 December 2020

The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum,

1 reference

12 December 2020

A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas

1 reference

12 December 2020

T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRI3488

1 reference

29 August 2017

0 references

1 reference